A host of pressures — patient recruitment and retention, cost and efficiency, and regulatory — have researchers seeking out novel approaches to clinical trials. Among them are virtual trials, which are often touted as a solution to many of these problems. Still, challenges and concerns remain, resulting in slow industry adoption.